MacroGenics (MGNX) Insider Trading & Ownership $3.23 +0.07 (+2.22%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MacroGenics (NASDAQ:MGNX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage11.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$1.28 M Get MGNX Insider Trade Alerts Want to know when executives and insiders are buying or selling MacroGenics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MGNX Insider Buying and Selling by Quarter MacroGenics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/4/2024Jeffrey Stuart PetersVPSell51,395$15.55$799,192.25 2/26/2024Jeffrey Stuart PetersVPSell16,124$17.22$277,655.28 2/1/2024Ezio BonviniSVPSell13,316$15.00$199,740.00 (Data available from 1/1/2013 forward) MGNX Insider Trading Activity - Frequently Asked Questions Who is on MacroGenics's Insider Roster? The list of insiders at MacroGenics includes Edward Hurwitz, Ezio Bonvini, James Karrels, Jeffrey Stuart Peters, and Target N V Biotech. Learn more on insiders at MGNX. What percentage of MacroGenics stock is owned by insiders? 11.30% of MacroGenics stock is owned by insiders. Learn more on MGNX's insider holdings. Which MacroGenics insiders have been buying company stock? The following insiders have purchased MGNX shares in the last 24 months: Edward Hurwitz ($73,650.00), and Target N V Biotech ($4,256,000.00). How much insider buying is happening at MacroGenics? Insiders have purchased a total of 865,000 MGNX shares in the last 24 months for a total of $4,329,650.00 bought. Which MacroGenics insiders have been selling company stock? The following insiders have sold MGNX shares in the last 24 months: Ezio Bonvini ($549,842.40), and Jeffrey Stuart Peters ($1,109,240.69). How much insider selling is happening at MacroGenics? Insiders have sold a total of 118,403 MacroGenics shares in the last 24 months for a total of $1,659,083.09 sold. MacroGenics Key ExecutivesDr. Scott Koenig M.D. (Age 72)Ph.D., President, CEO & Director Compensation: $1.2MMr. James Karrels (Age 57)Senior VP, CFO & Corporate Secretary Compensation: $693.31kDr. Stephen L. Eck M.D. (Age 69)Ph.D., Senior VP of Clinical Development & Chief Medical Officer Compensation: $766.85kMr. Eric Blasius Risser (Age 51)Chief Operating Officer Compensation: $651.36kDr. Thomas M. Spitznagel Ph.D. (Age 57)Senior Vice President of Technical Operations Compensation: $550.97kDr. Ezio Bonvini M.D. (Age 70)Senior VP of Research & Chief Scientific Officer Compensation: $612.21kMr. Jeffrey Stuart Peters (Age 53)Senior VP, General Counsel & Corporate Compliance Officer Ms. Lynn Cilinski (Age 66)VP, Controller & Treasurer More Insider Trading Tools from MarketBeat Related Companies Septerna Insider Selling Avadel Pharmaceuticals Insider Selling Relay Therapeutics Insider Selling Prothena Insider Selling CorMedix Insider Selling Sana Biotechnology Insider Selling Replimune Group Insider Selling uniQure Insider Selling Pliant Therapeutics Insider Selling ORIC Pharmaceuticals Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Small-Cap Stocks Insiders and Institutions Are Buying3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys This page (NASDAQ:MGNX) was last updated on 1/24/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredThe Stock I’m Calling My #1 of the DecadeThe stock I reveal right here is my #1 stock of the decade. In fact, it might be my favorite stock ever. ...InvestorPlace | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDonald Trump is about to free crypto from its chains …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MacroGenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MacroGenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
